Albert Bourla, Pfizer chairman and CEO, joins CNBC's 'Power Lunch' to discuss the company's focus for 2025, whether bird flu is the next pandemic, and more.

Trump says he wants to “reshore” U.S. companies, bringing their business activities and tax dollars back home. That would be ...

With the US readying itself for Donald Trump's inauguration early next week, what impact will his second term in the White ...

A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

And regular polling carried out by YouGov suggests adults are increasingly likely to say that vaccines have harmful side effects that are not being disclosed to the public. The proportion saying that ...

Raised in Grand Rapids, Marsha attended Lee and Kentwood High Schools, where she developed a love for performance. As a baton ...

The list below is not an endorsement. Its intention is to highlight the agencies that were shortlisted for the creative agency of the year award category by a jury of 29 client-side marketers who ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

The higher you go, the scarier it gets. Many investors are more leery of ultra-high dividend yields because they're afraid ...

Pfizer is expected to rebound in 2025 with growth stabilized and dividend growth to continue. Learn why PFE stock is a Buy.

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...